This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
Application deadline: 11 Nov 2024
Institute: Mark Foundation for Cancer Research
More information: https://themarkfoundation.org/drug-discovery-award-3/
The Mark Foundation for Cancer Research is dedicated to accelerating exciting academic discoveries into new therapies and platforms that will substantially improve outcomes for cancer patients. Currently, there are few options for academic scientists to obtain the resources and know-how to advance drug discovery efforts for promising new cancer targets.
To stem this gap, The Mark Foundation has established the Drug Discovery Award program. Through this program, The Mark Foundation aligns with investigators working to discover and progress a new therapeutic agent into preclinical development, providing not only resources to support post-target validation through early lead development but also the expertise of seasoned biopharma R&D scientists who will advise on activities on the critical path to developing a new therapeutic agent.
The application process begins with a concept letter stage consisting of a 2-page description of the project. The concept letter submission portal opens on September 18, 2024, and letters are due by November 11, 2024. Invitations for full applications will be issued in January 2025.
Award Details
Visit the Award website for full information and eligibility requirements